{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:07:39Z","timestamp":1787731659520,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,24]]},"DOI":"10.7759\/cureus.13527","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:15:42Z","timestamp":1614140142000},"source":"Crossref","is-referenced-by-count":17,"title":["Treatment Options in Vulvar Lichen Sclerosus: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Nilanchali","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prafull","family":"Ghatage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0019","article-title":"Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma","volume":"25","author":"Bleeker MCG","year":"2016","unstructured":"Bleeker MCG, Visser PJ, Overbeek LIH, van Beurden M, Berkhof J. Lichen sclerosus: incidence and risk of vulvar squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2016, 25:1224-30. 10.1158\/1055-9965.EPI-16-0019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e3182494e8c","article-title":"2011 ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis","volume":"16","author":"Lynch PJ","year":"2012","unstructured":"Lynch PJ, Moyal-Barracco M, Scurry J, Stockdale C. 2011 ISSVD terminology and classification of vulvar dermatological disorders: an approach to clinical diagnosis. J Low Genit Tract Dis. 2012, 16:339-44. 10.1097\/LGT.0b013e3182494e8c","journal-title":"J Low Genit Tract Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7480754","article-title":"Etiology, clinical features, and diagnosis of vulvar lichen sclerosus: a scoping review","volume":"2020","author":"Singh N","year":"2020","unstructured":"Singh N, Ghatage P. Etiology, clinical features, and diagnosis of vulvar lichen sclerosus: a scoping review. Obstet Gynecol Int. 2020, 2020:7480754. 10.1155\/2020\/7480754","journal-title":"Obstet Gynecol Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008240.pub2","article-title":"Topical interventions for genital lichen sclerosus","volume":"2011","author":"Chi C","year":"2011","unstructured":"Chi C, Kirtschig G, Baldo M, Brackenbury F, Lewis F, Wojnarowska F. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev. 2011, 2011:CD008240. 10.1002\/14651858.CD008240.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb00626.x","article-title":"The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream","volume":"124","author":"Dalziel KL","year":"1991","unstructured":"Dalziel KL, Millard PR, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol. 1991, 124:461-4. 10.1111\/j.1365-2133.1991.tb00626.x","journal-title":"Br J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee A","year":"2015","unstructured":"Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015, 151:1061-7. 10.1001\/jamadermatol.2015.0643","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13136","article-title":"Evidence-based (S3) guideline on (anogenital) lichen sclerosus","volume":"29","author":"Kirtschig G","year":"2015","unstructured":"Kirtschig G, Becker K, G\u00fcnthert A, et al.. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. J Eur Acad Dermatol Venereol. 2015, 29:1-43. 10.1111\/jdv.13136","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.6.702","article-title":"Does treatment of vulvar lichen sclerosus influence its prognosis?","volume":"140","author":"Cooper SM","year":"2004","unstructured":"Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis?. Arch Dermatol. 2004, 140:702-6. 10.1001\/archderm.140.6.702","journal-title":"Arch Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2010.01142.x","article-title":"Long-term management of vulval lichen sclerosus in adult women","volume":"50","author":"Bradford J","year":"2010","unstructured":"Bradford J, Fischer G. Long-term management of vulval lichen sclerosus in adult women. Aust N Z J Obstet Gynaecol. 2010, 50:148-52. 10.1111\/j.1479-828X.2010.01142.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2012.12.006","article-title":"EMAS clinical guide: vulvar lichen sclerosus in peri and postmenopausal women","volume":"74","author":"P\u00e9rez-L\u00f3pez FR","year":"2013","unstructured":"P\u00e9rez-L\u00f3pez FR, Ceausu I, Depypere H, et al.. EMAS clinical guide: vulvar lichen sclerosus in peri and postmenopausal women. Maturitas. 2013, 74:279-82. 10.1016\/j.maturitas.2012.12.006","journal-title":"Maturitas"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.6.709","article-title":"Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease","volume":"140","author":"Vilmer C","year":"2004","unstructured":"Vilmer C, Balloy B, Porcher R, et al.. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol. 2004, 140:709-12. 10.1001\/archderm.140.6.709","journal-title":"Arch Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1360990","article-title":"Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment?","volume":"29","author":"Corazza M","year":"2018","unstructured":"Corazza M, Virgili A, Toni G, Borghi A. Mometasone furoate in the treatment of vulvar lichen sclerosus: could its formulation influence efficacy, tolerability and adherence to treatment?. J Dermatolog Treat. 2018, 29:305-9. 10.1080\/09546634.2017.1360990","journal-title":"J Dermatolog Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000083513","article-title":"The outcome after cryosurgery and intralesional steroid injection in vulvar lichen sclerosus corresponds to preoperative histopathological findings","volume":"210","author":"St\u00fccker M","year":"2005","unstructured":"St\u00fccker M, Grape J, Bechara FG, Hoffmann K, Altmeyer P. The outcome after cryosurgery and intralesional steroid injection in vulvar lichen sclerosus corresponds to preoperative histopathological findings. Dermatology. 2005, 210:218-22. 10.1159\/000083513","journal-title":"Dermatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e31823da7e8","article-title":"Lichen sclerosus: a 5-year follow-up after topical, subdermal, or combined therapy","volume":"16","author":"Ventolini G","year":"2012","unstructured":"Ventolini G, Swenson KM, Galloway ML. Lichen sclerosus: a 5-year follow-up after topical, subdermal, or combined therapy. J Low Genit Tract Dis. 2012, 16:271-4. 10.1097\/LGT.0b013e31823da7e8","journal-title":"J Low Genit Tract Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.8","article-title":"Tacrolimus ointment for the treatment of vulvar lichen sclerosus","volume":"48","author":"Assmann T","year":"2003","unstructured":"Assmann T, Becker-Wegerich P, Grewe M, Megahed M, Ruzicka T. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol. 2003, 48:935-7. 10.1067\/mjd.2003.8","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.7.922","article-title":"Successful treatment of anogenital lichen sclerosus with topical tacrolimus","volume":"139","author":"B\u00f6hm M","year":"2003","unstructured":"B\u00f6hm M, Frieling U, Luger TA, Bonsmann G. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. Arch Dermatol. 2003, 139:922-4. 10.1001\/archderm.139.7.922","journal-title":"Arch Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.02.019","article-title":"A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus","volume":"71","author":"Funaro D","year":"2014","unstructured":"Funaro D, Lovett A, Leroux N, Powell J. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2014, 71:84-91. 10.1016\/j.jaad.2014.02.019","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.06.011","article-title":"A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus","volume":"64","author":"Goldstein A","year":"2011","unstructured":"Goldstein A, Creasey A, Pfau R, Phillips D, Burrows LJ. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2011, 64:99-104. 10.1016\/j.jaad.2010.06.011","journal-title":"J Am Acad Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07446.x","article-title":"Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus","volume":"155","author":"Hengge U","year":"2006","unstructured":"Hengge U, Krause W, Hofmann H, et al.. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol. 2006, 155:1021-8. 10.1111\/j.1365-2133.2006.07446.x","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1054777","article-title":"A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor","volume":"27","author":"Anderson K","year":"2016","unstructured":"Anderson K, Ascanio NM, Kinney MA, Krowchuk DP, Jorizzo JL. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. J Dermatolog Treat. 2016, 27:64-6. 10.3109\/09546634.2015.1054777","journal-title":"J Dermatolog Treat"},{"key":"ref21","article-title":"Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation","volume":"38","author":"Bracco GL","year":"1993","unstructured":"Bracco GL, Carli P, Sonni L, et al.. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med. 1993, 38:37-40.","journal-title":"J Reprod Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(94)90309-3","article-title":"Topical testosterone in the treatment of vulvar lichen sclerosus","volume":"46","author":"Sideri M","year":"1994","unstructured":"Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet. 1994, 46:53-6. 10.1016\/0020-7292(94)90309-3","journal-title":"Int J Gynaecol Obstet"},{"key":"ref23","article-title":"Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy","volume":"40","author":"Virgili A","year":"1995","unstructured":"Virgili A, Corazza M, Bianchi A, et al.. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J Reprod Med. 1995, 40:614-8.","journal-title":"J Reprod Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2015.2595","article-title":"Topical tretinoin in the treatment of vulvar lichen sclerosus: an advisable option?","volume":"25","author":"Borghi A","year":"2015","unstructured":"Borghi A, Corazza M, Minghetti S, Virgili A. Topical tretinoin in the treatment of vulvar lichen sclerosus: an advisable option?. Eur J Dermatol. 2015, 25:404-9. 10.1684\/ejd.2015.2595","journal-title":"Eur J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0020-7292(96)02768-3","article-title":"Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus","volume":"55","author":"Origoni M","year":"1996","unstructured":"Origoni M, Ferrari D, Rossi M, Gandini F, Sideri M, Ferrari A. Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet. 1996, 55:259-64. 10.1016\/s0020-7292(96)02768-3","journal-title":"Int J Gynaecol Obstet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02978.x","article-title":"Treatment of lichen sclerosus with antibiotics","volume":"45","author":"Shelley WB","year":"2006","unstructured":"Shelley WB, Shelley ED, Amurao CV. Treatment of lichen sclerosus with antibiotics. Int J Dermatol. 2006, 45:1104-6. 10.1111\/j.1365-4632.2006.02978.x","journal-title":"Int J Dermatol"},{"key":"ref27","article-title":"Safety and efficacy of human fibroblast lysate cream for vulvar lichen sclerosus: a randomized placebo-controlled trial","volume":"95","author":"Goldstein AT","year":"2015","unstructured":"Goldstein AT, Burrows LJ, Belkin ZR, Pfau R, Bremmer M, Goldfinger C, Dreher F. Safety and efficacy of human fibroblast lysate cream for vulvar lichen sclerosus: a randomized placebo-controlled trial. Acta Derm Venereol. 2015, 95:847-9.","journal-title":"Acta Derm Venereol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2013.1987","article-title":"Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient","volume":"23","author":"Virgili A","year":"2013","unstructured":"Virgili A, Minghetti S, Borghi A, Corazza M. Long-term maintenance therapy for vulvar lichen sclerosus: the results of a randomized study comparing topical vitamin E with an emollient. Eur J Dermatol. 2013, 23:189-94. 10.1684\/ejd.2013.1987","journal-title":"Eur J Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000512","article-title":"Fractionated CO2 laser as therapy in recalcitrant lichen sclerosus","volume":"24","author":"Balchander D","year":"2020","unstructured":"Balchander D, Nyirjesy P. Fractionated CO2 laser as therapy in recalcitrant lichen sclerosus. J Low Genit Tract Dis. 2020, 24:225-8. 10.1097\/LGT.0000000000000512","journal-title":"J Low Genit Tract Dis"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1001\/jamadermatol.2018.4461","article-title":"Recalcitrant vulvar lichen sclerosus treated with erbium YAG laser","volume":"155","author":"Hobson JG","year":"2019","unstructured":"Hobson JG, Ibrahim SF, Mercurio MG. Recalcitrant vulvar lichen sclerosus treated with erbium YAG laser. JAMA Dermatol. 2019, 155:254-6.","journal-title":"JAMA Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.7733","article-title":"UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial","volume":"150","author":"Terras S","year":"2014","unstructured":"Terras S, Gambichler T, Moritz RKC, St\u00fccker M, Kreuter A. UV-A1 phototherapy vs clobetasol propionate, 0.05%, in the treatment of vulvar lichen sclerosus: a randomized clinical trial. JAMA Dermatol. 2014, 150:621-7. 10.1001\/jamadermatol.2013.7733","journal-title":"JAMA Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2019.101596","article-title":"Evaluation of the efficacy of 5-aminolevulinic acid photodynamic therapy for the treatment of vulvar lichen sclerosus","volume":"29","author":"Li Z","year":"2020","unstructured":"Li Z, Wang Y, Wang J, et al.. Evaluation of the efficacy of 5-aminolevulinic acid photodynamic therapy for the treatment of vulvar lichen sclerosus. Photodiagnosis Photodyn Ther. 2020, 29:101596. 10.1016\/j.pdpdt.2019.101596","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2017.12.003","article-title":"5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: series of ten cases","volume":"21","author":"Lan T","year":"2018","unstructured":"Lan T, Zou Y, Hamblin MR, Yin R. 5-Aminolevulinic acid photodynamic therapy in refractory vulvar lichen sclerosus et atrophicus: series of ten cases. Photodiagnosis Photodyn Ther. 2018, 21:234-8. 10.1016\/j.pdpdt.2017.12.003","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2341","article-title":"Comparison of 5-aminolevulinic acid photodynamic therapy and clobetasol propionate in treatment of vulvar lichen sclerosus","volume":"15","author":"Shi L","year":"2016","unstructured":"Shi L, Miao F, Zhang LL, et al.. Comparison of 5-aminolevulinic acid photodynamic therapy and clobetasol propionate in treatment of vulvar lichen sclerosus. Acta Derm Venereol. 2016, 15:684-8. 10.2340\/00015555-2341","journal-title":"Acta Derm Venereol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(98)00321-4","article-title":"Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid","volume":"93","author":"Hillemanns P","year":"1999","unstructured":"Hillemanns P, Untch M, Pr\u00f6ve F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol. 1999, 93:71-4. 10.1016\/s0029-7844(98)00321-4","journal-title":"Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1046\/j.1610-0387.2003.03517.x","article-title":"[Cryosurgery--the last resort or a surgical alternative in the treatment of lichen sclerosus et atrophicus of the vulva (LSAV)?]","volume":"1","author":"Kastner U","year":"2003","unstructured":"Kastner U, Altmeyer P. [Cryosurgery--the last resort or a surgical alternative in the treatment of lichen sclerosus et atrophicus of the vulva (LSAV)?]. J Dtsch Dermatol Ges. 2003, 1:206-11. 10.1046\/j.1610-0387.2003.03517.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.10.014","article-title":"Vulvar lichen sclerosus: A new regenerative approach through fat grafting","volume":"139","author":"Boero V","year":"2015","unstructured":"Boero V, Brambilla M, Sipio E, et al.. Vulvar lichen sclerosus: A new regenerative approach through fat grafting. Gynecol Oncol. 2015, 139:471-5. 10.1016\/j.ygyno.2015.10.014","journal-title":"Gynecol Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000520","article-title":"Fat grafting improves fibrosis and scarring in vulvar lichen sclerosus: results from a prospective cohort study","volume":"24","author":"Almadori A","year":"2020","unstructured":"Almadori A, Hansen E, Boyle D, et al.. Fat grafting improves fibrosis and scarring in vulvar lichen sclerosus: results from a prospective cohort study. J Low Genit Tract Dis. 2020, 24:305-310. 10.1097\/LGT.0000000000000520","journal-title":"J Low Genit Tract Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000440","article-title":"Fact or fiction? Adipose-derived stem cells and platelet-rich plasma for the treatment of vulvar lichen sclerosus","volume":"23","author":"Eshtiaghi P","year":"2019","unstructured":"Eshtiaghi P, Sadownik LA. Fact or fiction? Adipose-derived stem cells and platelet-rich plasma for the treatment of vulvar lichen sclerosus. J Low Genit Tract Dis. 2019, 23:65-70. 10.1097\/LGT.0000000000000440","journal-title":"J Low Genit Tract Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12617","article-title":"Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: results of efficacy and tolerability","volume":"29","author":"Borghi A","year":"2015","unstructured":"Borghi A, Corazza M, Minghetti S, Toni G, Virgili A. Avocado and soybean extracts as active principles in the treatment of mild-to-moderate vulvar lichen sclerosus: results of efficacy and tolerability. J Eur Acad Dermatol Venereol. 2015, 29:1225-30. 10.1111\/jdv.12617","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(93)90622-p","article-title":"Subcutaneous injection of triamcinolone acetonide in the treatment of chronic vulvar pruritus","volume":"169","author":"Kelly RA","year":"1993","unstructured":"Kelly RA, Foster DC, Woodruff JD. Subcutaneous injection of triamcinolone acetonide in the treatment of chronic vulvar pruritus. Am J Obstet Gynecol. 1993, 169:568-70. 10.1016\/0002-9378(93)90622-p","journal-title":"Am J Obstet Gynecol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(94)70021-4","article-title":"Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study","volume":"30","author":"Bousema MT","year":"1994","unstructured":"Bousema MT, Romppanen U, Geiger JM, Baudin M, V\u00e4h\u00e4-Eskeli K, Vartiainen J, Vuopala S. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. 1994, 30:225-31. 10.1016\/s0190-9622(94)70021-4","journal-title":"J Am Acad Dermatol"},{"key":"ref43","article-title":"[Study on the risk factors of 100 cases with vulvar dystrophy]","volume":"24","author":"Tang GX","year":"2003","unstructured":"Tang GX, Wu X, Chen JP, Zhou BS. [Study on the risk factors of 100 cases with vulvar dystrophy]. Zhonghua Liu Xing Bing Xue Za Zhi. 2003, 24:932-4.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1159\/000367788","article-title":"What differentiates symptomatic from asymptomatic women with lichen sclerosus?","volume":"79","author":"Vieira BP","year":"2015","unstructured":"Vieira BP, Lima SJ, Cavaco-Gomes J, Beires J, Martinez-de-Oliveira J. What differentiates symptomatic from asymptomatic women with lichen sclerosus?. Gynecol Obstet Invest. 2015, 79:263-8. 10.1159\/000367788","journal-title":"Gynecol Obstet Invest"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2018.12.012","article-title":"Clitoral Phimosis: Effects on Female Sexual Function and Surgical Treatment Outcomes","volume":"16","author":"Chmel R","year":"2019","unstructured":"Chmel R, Novackova M, Fait T, Z\u00e1me\u010dn\u00edk L, Krej\u010dov\u00e1 L, Pastor Z. Clitoral Phimosis: Effects on Female Sexual Function and Surgical Treatment Outcomes. J Sex Med. 2019, 16:257-66. 10.1016\/j.jsxm.2018.12.012","journal-title":"J Sex Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002919","article-title":"External use of an oxidized regenerated cellulose agent in the treatment of labial agglutination in postmenopausal women","volume":"132","author":"Wyman AM","year":"2018","unstructured":"Wyman AM, Lafranchise E, Lynch C. External use of an oxidized regenerated cellulose agent in the treatment of labial agglutination in postmenopausal women. Obstet Gynecol. 2018, 132:1238-40. 10.1097\/AOG.0000000000002919","journal-title":"Obstet Gynecol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199603000-00023","article-title":"Surgical treatment of vulvar lichen sclerosus: a review","volume":"51","author":"Abramov Y","year":"1996","unstructured":"Abramov Y, Elchalal U, Abramov D, Goldfarb A, Schenker JG. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv. 1996, 51:193-9. 10.1097\/00006254-199603000-00023","journal-title":"Obstet Gynecol Surv"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12273","article-title":"Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study","volume":"168","author":"Virgili A","year":"2013","unstructured":"Virgili A, Minghetti S, Borghi A, Corazza M. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study. Br J Dermatol. 2013, 168:1316-24. 10.1111\/bjd.12273","journal-title":"Br J Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.5.525","article-title":"Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus","volume":"135","author":"Garzon MC","year":"1999","unstructured":"Garzon MC, Paller AS. Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol. 1999, 135:525-8. 10.1001\/archderm.135.5.525","journal-title":"Arch Dermatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2012.11.010","article-title":"Low-concentration topical tacrolimus for the treatment of anogenital lichen sclerosus in childhood: maintenance treatment to reduce recurrence","volume":"26","author":"Li Y","year":"2013","unstructured":"Li Y, Xiao Y, Wang H, Li H, Luo X. Low-concentration topical tacrolimus for the treatment of anogenital lichen sclerosus in childhood: maintenance treatment to reduce recurrence. J Pediatr Adolesc Gynecol. 2013, 26:239-42. 10.1016\/j.jpag.2012.11.010","journal-title":"J Pediatr Adolesc Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/49721-treatment-options-in-vulvar-lichen-sclerosus-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:24:33Z","timestamp":1707488673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/49721-treatment-options-in-vulvar-lichen-sclerosus-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":50,"URL":"https:\/\/doi.org\/10.7759\/cureus.13527","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,24]]}}}